Brief: 4D Molecular Therapeutics Says On Sept 30, Appointed Ashoo Gupta As Principal Financial Officer - SEC Filing
02/10/2025 21:31
Oct 2 (Reuters) - 4D Molecular Therapeutics Inc FDMT.O: 4D MOLECULAR THERAPEUTICS INC - ON SEPT 30, APPOINTED ASHOO GUPTA AS PRINCIPAL FINANCIAL OFFICER - SEC FILING Source text: [ID:n0001193125-25-228289] Further company coverage: FDMT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on 4D Molecular Therapeutics
See all news4D Molecular Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
4D Molecular Therapeutics Q2 net loss widens
Brief: 4D Molecular Therapeutics Q2 Net Income USD -72.936 Million Vs. IBES Estimate USD -70.3 Million
4D Molecular Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview
Brief: 4d Molecular Therapeutics Says 4D-150 Continues To Be Well Tolerated With No New Safety Findings